Lihua Wang
Bengbu, 233004, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Fluoxetine-associated adverse event signals with a focus on seizure: A study based on the FAERS database, network pharmacology, and molecular docking.
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: April 28, 2026
Iparomlimab and tuvonralimab in previously treated patients with cervical cancer.
Journal: Cell reports. Medicine
Published: May 29, 2025
Global burden and trends in ovarian cancer attributable to environmental risks and occupational risks in females aged 20-49 from 1990 to 2021, with projections to 2050: a cross-sectional study.
Journal: BMC public health
Published: April 12, 2025
The impact of bevacizumab intraperitoneal perfusion combined with paclitaxel and platinum-based chemotherapy on serum stromal-derived factor-1α (SDF-1α) and chemokine ligand 5 (CXCL-5) levels in patients with ovarian cancer after tumor cell debulking surgery.
Journal: Anti-cancer drugs
Published: January 06, 2025
The molecular mechanism of gemcitabine in inhibiting the HIF-1α/VEGFB/FGF2/FGFR1 signaling pathway for ovarian cancer treatment.
Journal: Discover oncology
Published: June 13, 2024
Squalene monooxygenase (SQLE) protects ovarian cancer cells from ferroptosis.
Journal: Scientific reports
Published: December 27, 2023
IL-17A/lL-17RA reduces cisplatin sensitivity of ovarian cancer SKOV3 cells by regulating autophagy
Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University
Published: November 27, 2020
Association between diabetes mellitus and subsequent ovarian cancer in women: A systematic review and meta-analysis of cohort studies.
Journal: Medicine
Published: April 20, 2017
Identifying Gene Signature for the Detection of Ovarian Cancer Based on the Achieved Related Genes.
Journal: Gynecologic and obstetric investigation
Published: April 11, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026